The Duchess of Cambridge has shared a photo of herself receiving the coronavirus vaccine.
Posting on Twitter, she said she had got the injection at the Science Museum in London.
“Yesterday I received my first dose of the COVID-19 vaccine at London’s Science Museum. I’m hugely grateful to everyone who is playing a part in the rollout – thank you for everything you are doing,” she posted.
Responding to the Kensington Palace tweet, Health Secretary Matt Hancock, who was also jabbed at the Science Museum, said: “In the last fortnight more than half of all people in their 30s have been vaccinated.
“Delighted HRH The Duchess of Cambridge was able to get her jab at the Science Museum.”
It comes a few days after Prince William, who contracted COVID-19 last spring, got his jab.
The duke was reportedly hit “pretty hard” by the virus and at one stage struggled to breathe, although he was able to manage telephone and online engagements while being treated by royal doctors.
People over 30 are now eligible for vaccination, leaving only adults aged between 18 and 29 still having to wait.
The Queen and Prince of Wales are among other members of the royal family to be vaccinated as the rollout of jabs reaches millions of people across the country.
More than 32 million people have been vaccinated with a first dose in England, almost three-quarters of the total adult population, while more than 20 million people have had both doses.
People aged 39 and under, and pregnant women, are being offered the Pfizer or Moderna COVID vaccine in line with recently updated guidance.
The programme, which is now going down in two-year increments, went from 37-year-olds to 30-year-olds in 10 days.
Like England, Scotland is also offering jabs to those aged 30 or above, while in Northern Ireland and Wales, you can get vaccinated if you are aged 18 or over.
Some areas, where the Indian variant is spreading, have increased the speed of their vaccine rollout over the past two weeks to try to protect people.
A new vaccine, produced by French firm Sanofi and GlaxoSmithKline (GSK) will begin within weeks, the firms have said.
The two companies are currently in Phase 3 of their trials, which will see 35,000 adult volunteers receive their coronavirus jab across the US, Asia, Africa, and Latin America.
The UK has ordered 60 million doses of the vaccine, joining existing supplies from Oxford-Astrazeneca, Moderna, and Pfizer-BioNTech.
Source: Read Full Article